Literature DB >> 28300660

Mechanistic understanding of the cysteine capping modifications of antibodies enables selective chemical engineering in live mammalian cells.

Xiaotian Zhong1, Tao He2, Amar S Prashad3, Wenge Wang4, Justin Cohen2, Darren Ferguson2, Amy S Tam2, Eric Sousa2, Laura Lin2, Lioudmila Tchistiakova2, Scott Gatto2, Aaron D'Antona2, Yen-Tung Luan4, Weijun Ma2, Richard Zollner2, Jing Zhou2, Bo Arve3, Will Somers2, Ronald Kriz2.   

Abstract

Protein modifications by intricate cellular machineries often redesign the structure and function of existing proteins to impact biological networks. Disulfide bond formation between cysteine (Cys) pairs is one of the most common modifications found in extracellularly-destined proteins, key to maintaining protein structure. Unpaired surface cysteines on secreted mammalian proteins are also frequently found disulfide-bonded with free Cys or glutathione (GSH) in circulation or culture, the mechanism for which remains unknown. Here we report that these so-called Cys-capping modifications take place outside mammalian cells, not in the endoplasmic reticulum (ER) where oxidoreductase-mediated protein disulfide formation occurs. Unpaired surface cysteines of extracellularly-arrived proteins such as antibodies are uncapped upon secretion before undergoing disulfide exchange with cystine or oxidized GSH in culture medium. This observation has led to a feasible way to selectively modify the nucleophilic thiol side-chain of cell-surface or extracellular proteins in live mammalian cells, by applying electrophiles with a chemical handle directly into culture medium. These findings provide potentially an effective approach for improving therapeutic conjugates and probing biological systems.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Cys-capping modification; Free thiol; Live mammalian cells; Selective chemical engineering; Unpaired surface cysteine

Mesh:

Substances:

Year:  2017        PMID: 28300660     DOI: 10.1016/j.jbiotec.2017.03.006

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  4 in total

1.  Structural and Biochemical Characterization of Cysteinylation in Broadly Neutralizing Antibodies to HIV-1.

Authors:  Oluwarotimi Omorodion; Ian A Wilson
Journal:  J Mol Biol       Date:  2021-10-16       Impact factor: 5.469

2.  In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI-MS spectrum.

Authors:  Luis Ariel Espinosa; Yassel Ramos; Ivan Andújar; Enso Onill Torres; Gleysin Cabrera; Alejandro Martín; Diamilé Roche; Glay Chinea; Mónica Becquet; Isabel González; Camila Canaán-Haden; Elías Nelson; Gertrudis Rojas; Beatriz Pérez-Massón; Dayana Pérez-Martínez; Tamy Boggiano; Julio Palacio; Sum Lai Lozada Chang; Lourdes Hernández; Kathya Rashida de la Luz Hernández; Saloheimo Markku; Marika Vitikainen; Yury Valdés-Balbín; Darielys Santana-Medero; Daniel G Rivera; Vicente Vérez-Bencomo; Mark Emalfarb; Ronen Tchelet; Gerardo Guillén; Miladys Limonta; Eulogio Pimentel; Marta Ayala; Vladimir Besada; Luis Javier González
Journal:  Anal Bioanal Chem       Date:  2021-11-05       Impact factor: 4.478

3.  Cysteine metabolic engineering and selective disulfide reduction produce superior antibody-drug-conjugates.

Authors:  Renée Procopio-Melino; Frank W Kotch; Amar S Prashad; Jose M Gomes; Wenge Wang; Bo Arve; Andrew Dawdy; Lawrence Chen; Justin Sperry; Christine Hosselet; Tao He; Ronald Kriz; Laura Lin; Kimberly Marquette; Lioudmila Tchistiakova; Will Somers; Jason C Rouse; Xiaotian Zhong
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

4.  Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies.

Authors:  Irina V Kholodenko; Daniel V Kalinovsky; Elena V Svirshchevskaya; Igor I Doronin; Maria V Konovalova; Alexey V Kibardin; Tatyana V Shamanskaya; Sergey S Larin; Sergey M Deyev; Roman V Kholodenko
Journal:  Molecules       Date:  2019-10-24       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.